Cargando…
Persistent post-discharge symptoms after COVID-19 in rheumatic and musculoskeletal diseases
OBJECTIVES: We aimed to describe persistent symptoms and sequelae in patients with rheumatic and musculoskeletal diseases (RMD) after admission owing to coronavirus disease 2019 (COVID-19), assessing the role of autoimmune rheumatic diseases (ARDs) compared with non-autoimmune rheumatic and musculos...
Autores principales: | Leon, Leticia, Perez-Sancristobal, Ines, Madrid, Alfredo, Lopez-Pedraza, Leticia, Colomer, Jose Ignacio, Lerma, Sergio, Lois, Pia, Mucientes, Arkaitz, Rodriguez-Rodriguez, Luis, Fernandez-Gutierrez, Benjamin, Abasolo, Lydia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882379/ https://www.ncbi.nlm.nih.gov/pubmed/35233480 http://dx.doi.org/10.1093/rap/rkac008 |
Ejemplares similares
-
Mortality related to COVID-19 in patients with rheumatic and musculoskeletal diseases, first wave of the outbreak: a single-center study
por: Nuñez, Dalifer Freites, et al.
Publicado: (2022) -
Hospital admissions in inflammatory rheumatic diseases during the peak of COVID-19 pandemic: incidence and role of disease-modifying agents
por: Fernandez-Gutierrez, Benjamin, et al.
Publicado: (2021) -
Influence of colchicine prescription in COVID-19-related hospital admissions: a survival analysis
por: Madrid-García, Alfredo, et al.
Publicado: (2021) -
Predictors of health-related quality of life in musculoskeletal disease patients: a longitudinal analysis
por: Madrid-García, Alfredo, et al.
Publicado: (2021) -
RNA sequencing of mesenchymal stem cells reveals a blocking of differentiation and immunomodulatory activities under inflammatory conditions in rheumatoid arthritis patients
por: Lamas, Jose Ramon, et al.
Publicado: (2019)